(Q33204609)

23 July 2017

title

Development of an in vitro-based potency assay for anthrax vaccine (English)

1 reference

23 July 2017

Little SF

1

1 reference

23 July 2017

Webster WM

2

1 reference

23 July 2017

Ivins BE

3

1 reference

23 July 2017

Fellows PF

4

1 reference

23 July 2017

Norris SL

5

1 reference

23 July 2017

Andrews GP

6

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

23 July 2017

1 reference

23 July 2017

volume

22

1 reference

23 July 2017

issue

21-22

1 reference

23 July 2017

page(s)

2843-2852

1 reference

Potency testing of bacterial vaccines for human use.

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

The development of new vaccines against Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Identification of the cellular receptor for anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Serum protease cleavage of Bacillus anthracis protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

In vitro correlate of immunity in a rabbit model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Passive transfer of protection against Bacillus anthracis infection in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Search for correlates of protective immunity conferred by anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

A modified method to induce immune polyclonal ascites fluid in BALB/c mice using Sp2/0-Ag14 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Field Evaluation of a Human Anthrax Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.12.027

1 reference

23 July 2017

1 reference